About the Journal

Indian Journal of Drugs and Diseases (IJDAD) is the official journal of the "Indian Society for Education and Environment" (iSee). Lifestyle activities in society have undergone number of physical and psychological changes that may result in genetic changes manifested in future generations. The relationship between drugs and diseases is inevitably important for society. Results of research must be accessible, thereby creating awareness on the availability of drugs against diseases affecting society. IJDAD is expected to assume a vital role in communication, information and education regarding development and establishment of drug therapies for diseases affecting society.

Aim and Scope

Indian Journal of Drugs and Diseases is the leading open-access journal, providing a platform for publishing innovative and research articles. As an open access journal, articles in Indian Journal of Drugs and Diseases will always be freely available online and readily accessible.


IJDAD will provide information regarding various approaches of using drugs to control diseases; highlighting epidemiology, clinical diagnosis, Pharmacology and the emerging trends on established drug therapies.


IJDAD provides the society with expert reviews, original research articles, clinical trials, analysis, news, letters, technical reports and case studies.

Subject Theme

Topics suitable for publication will be included (but it is not limited to)

  • Diseases- Plethora affecting community- viz
    • Communicable and Non-communicable
    • Geriatric
    • Environmental diseases
  • Drug-informatics
  • Gene Therapeutics
  • Pharmaceutical Analysis
  • Pharmaceutical Chemistry
  • Pharmaceutics
  • Pharmaceutical technology
  • Hospital pharmacy
  • Industrial pharmacy
  • Forensic pharmacy
  • Pharmacognosy and Advanced Pharmacognosy
  • Pharmacogenomics and Toxicogenomics
  • Pharmacology and Toxicology
  • Pharmacogenetics
  • Pharmacotherapy
  • Pharmacovigilance
  • Pharmacoeconomics
  • Pre-clinical studies in various animal models
  • Clinical-Pharmacological aspects pertaining to –viz
    • Clinical
    • Community
    • Medicinal chemistry
    • Analysis
    • Biotechnological
    • Microbiological
    • Management
    • Drugs
    • Design, Discovery, development with strategies
    • Business
    • Regulatory issues
    • Computational chemistry and molecular drug design
    • Hospital management


The journal is addressed to both practicing professionals and researchers in the field of Drugs and Diseases, professionals in academia, former researchers, students and other specialists interested in the results of scientific research and related subjects covered by the journal.